Increased exacerbations and hospitalizations among PI*MZ compared to PI*MM individuals: an electronic health record analysis

Increased exacerbations and hospitalizations among PIMZ compared to PIMM individuals: an electronic health record analysis

Abstract Background The best described endotype of COPD is alpha-1 antitrypsin (AAT) deficiency, due to a genetic abnormality in the SERPINA1 gene. Common deficient PI variants are the Z and S variants. Homozygotes for the Z allele (PI*ZZ individuals) carry the genotype most commonly associated with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Vickram Tejwani, Yifan Wang, Lauren Munoz Tremblay, Elizabeth Azzato, Arianne K. Baldomero, Christine Wendt, Amy Attaway, Russell Bowler, Umur Hatipoglu, Rebecca Hutton, Charlie Strange, Xiaofeng Wang, Victor E. Ortega, Joe Zein, James K. Stoller
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	Respiratory Research
Subjects:	Alpha-1 antitrypsin COPD Exacerbations Healthcare utilizations
Online Access:	https://doi.org/10.1186/s12931-025-03322-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

“Alpha-1, are you in? (C)harlie (O)scar (P)appa (D)elta, over!”
by: G. L. Muntingh
Published: (2016-01-01)

Occurrence of Emphysema in Individuals With Williams-Beuren SyndromeTake-home Points
by: Uddalak Majumdar, MD, et al.
Published: (2025-03-01)

Alpha-1 antitrypsin deficiency-associated panniculitis: a case report
by: Špela But, et al.
Published: (2025-06-01)

THE DIAGNOSTIC AND CLINICAL VALUE OF DETERMINATION OF α1-ANTITRYPSIN PHENOTYPE IN SYSTEMIC VASCULITIDES
by: M. Yu. Pervakova, et al.
Published: (2017-04-01)

Alpha-1 antitrypsin in COVID-19 patients: a dual-center screening study in Malaysia
by: Norsyuhadah Musa, et al.
Published: (2025-07-01)

Sequencing Alpha-1 MZ Individuals Shows Frequent Biallelic Mutations
by: Kimberly E. Foil, et al.
Published: (2018-01-01)

Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01)

Inflammation Promotes Aging‐Associated Oncogenesis in the Lung
by: Catherine Pham‐Danis, et al.
Published: (2025-03-01)

Chronic Obstructive Pulmonary Disease (COPD)
by: J.A. Ker, et al.
Published: (2003-05-01)

Administration of Purified Alpha-1 Antitrypsin in Salt-Loaded Hypertensive 129Sv Mice Attenuates the Expression of Inflammatory Associated Proteins in the Kidney
by: Van-Anh L. Nguyen, et al.
Published: (2025-06-01)

Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency
by: Paulo Henrique Ramos Feitosa, et al.
Published: (2024-12-01)

Characterization of the Mmalton carrier’s cohort within the EARCO (European Alpha- 1 Antitrypsin Research Collaboration) registry
by: Beatriz D. Ferraz, et al.
Published: (2025-04-01)

Accurate Indentification of Pathogenic Mutations Conferring α1-Antitrypsin Deficiency by a Novel Multiplexed Molecular AssayTake-home Points
by: Emily K. DeCurtis, BSc, et al.
Published: (2025-03-01)

Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye
by: Dilek Karadoğan, et al.
Published: (2024-12-01)

Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges
by: José Luis Lopez-Campos, et al.
Published: (2025-06-01)

Is PiSS Alpha-1 Antitrypsin Deficiency Associated with Disease?
by: Dawn McGee, et al.
Published: (2010-01-01)

Lactoferrin acute-phase protein and proteinase inhibitors in blood of patients with Q-wave myocardial infraction complicated by acute heart failure
by: K. P. Belokoneva, et al.
Published: (2012-06-01)

Identification of rice blast resistance genes Pi-1, Pi-2, Pi-33, Pi-40, Pi-ta, Pi-b
by: O. V. Shumskaya, et al.
Published: (2023-11-01)

COPD exacerbation: factors influencing hospitalization duration
by: Gashynova K.Yu.
Published: (2015-03-01)

a1-antitrypsin, a new biomarker of polycystic ovary syndrome by changing its expression and rhythm
by: Na Li, et al.
Published: (2025-05-01)

Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency
by: Ekin Seçinti, et al.
Published: (2025-02-01)

Alpha-1 Antitrypsin as a Regulatory Protease Inhibitor Modulating Inflammation and Shaping the Tumor Microenvironment in Cancer
by: Siyu Xiang, et al.
Published: (2025-01-01)

Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy
by: Atharv V. Oak, MEng, et al.
Published: (2025-02-01)

Is It Time Alpha-1 Antitrypsin Deficiency Had a Specific Patient Reported Outcome Measure? A Review
by: De Soyza J, et al.
Published: (2025-01-01)

Factors affecting the frequency of arthritis attacks in patients with gout not receiving urate-lowering therapy (results of a pilot retrospective study)
by: M. S. Eliseev, et al.
Published: (2024-06-01)

Prevalence of genetic mutations in Alpha-1 antitrypsin in patients with difficult-to-treat asthma in Colombia
by: Abraham Alí-Munive, et al.
Published: (2025-08-01)

Contents of plasmin, α1-antitrypsin and α2-macroglobulin in blood of patients with cerebral infarction and discircular encephalopathy before the treatment
by: N. A. Kuznetsova, et al.
Published: (2004-09-01)

Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes
by: Ilaria Ferrarotti, et al.
Published: (2025-12-01)

Alpha-1 antitrypsin reduces inflammation and vasculopathy in mice with oxygen-induced retinopathy
by: Varaporn Suphapimol, et al.
Published: (2025-02-01)

Alpha-1 antitripsyn deficiency and augmentation therapy in pregnancy: two case reports
by: Anna Annunziata, et al.
Published: (2024-12-01)

COPD exacerbation: anthropometric characteristics of patients and the frequency of hospital admissions
by: Gashynova K.Y.
Published: (2014-11-01)

Management of Asthma and COPD Exacerbations in Adults in the ICUKey PointsClinical QuestionClinical Question
by: Stephen A. Mein, MD, et al.
Published: (2025-03-01)

Risk factors for prolonged hospitalization as a marker for difficult-to-manage exacerbations of chronic obstructive lung disease (COPD): the DiMECO Study
by: Dorina Esendağlı, et al.
Published: (2024-11-01)

Do MZ twins have discordant experiences of friendship? A qualitative hypothesis-generating MZ twin differences study.
by: Kathryn Asbury, et al.
Published: (2017-01-01)

Eosinophil count and treatment response in COPD patients
by: CR Kiran, et al.
Published: (2025-07-01)

Burden of Exacerbations in Patients Newly Initiating an Inhaled Regimen for COPD: A Claims Analysis
by: Sethi S, et al.
Published: (2025-06-01)

Development of a small molecule that corrects misfolding and increases secretion of Z α1‐antitrypsin
by: David A Lomas, et al.
Published: (2021-01-01)

Effectiveness of influenza vaccination in preventing severe COPD exacerbations and pneumonia before, during, and after the COVID-19 pandemic: a retrospective cohort studyResearch in context
by: Sophia Eilat Tsanani, et al.
Published: (2025-06-01)

New laboratory biomarkers of rheumatoid arthritis
by: D. A. Dibrov
Published: (2021-05-01)

Influence of anthropometric characteristics on chronic obstructive pulmonary disease (COPD) prognosis in outpatients
by: K. Yu. Gashynova
Published: (2015-06-01)